Literature DB >> 18594554

Hypoperfusion of the cerebral white matter in multiple sclerosis: possible mechanisms and pathophysiological significance.

Jacques De Keyser1, Christel Steen, Jop P Mostert, Marcus W Koch.   

Abstract

Multiple sclerosis (MS) is a disease of the central nervous system characterized by patchy areas of demyelination, inflammation, axonal loss and gliosis, and a diffuse axonal degeneration throughout the so-called normal-appearing white matter (NAWM). A number of recent studies using perfusion magnetic resonance imaging in both relapsing and progressive forms of MS have shown a decreased perfusion of the NAWM, which does not appear to be secondary to axonal loss. The reduced perfusion of the NAWM in MS might be caused by a widespread astrocyte dysfunction, possibly related to a deficiency in astrocytic beta(2)-adrenergic receptors and a reduced formation of cAMP, resulting in a reduced uptake of K(+) at the nodes of Ranvier and a reduced release of K(+) in the perivascular spaces. Pathologic and imaging studies suggest that ischemic changes might be involved in the development of a subtype of focal demyelinating lesions (type III lesions), and there appears to exist a relationship between decreased white matter perfusion and cognitive dysfunction in patients with MS.

Entities:  

Mesh:

Year:  2008        PMID: 18594554     DOI: 10.1038/jcbfm.2008.72

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  47 in total

1.  Multiple sclerosis-related white matter microstructural change alters the BOLD hemodynamic response.

Authors:  Nicholas A Hubbard; Monroe Turner; Joanna L Hutchison; Austin Ouyang; Jeremy Strain; Larry Oasay; Saranya Sundaram; Scott Davis; Gina Remington; Ryan Brigante; Hao Huang; John Hart; Teresa Frohman; Elliot Frohman; Bharat B Biswal; Bart Rypma
Journal:  J Cereb Blood Flow Metab       Date:  2015-11-09       Impact factor: 6.200

2.  Multiple sclerosis and chronic cerebrospinal venous insufficiency: the neuroimaging perspective.

Authors:  M Filippi; M A Rocca; F Barkhof; R Bakshi; F Fazekas; O Khan; D Pelletier; A Rovira; J Simon
Journal:  AJNR Am J Neuroradiol       Date:  2011-02-03       Impact factor: 3.825

3.  Calibrated imaging reveals altered grey matter metabolism related to white matter microstructure and symptom severity in multiple sclerosis.

Authors:  Nicholas A Hubbard; Monroe P Turner; Minhui Ouyang; Lyndahl Himes; Binu P Thomas; Joanna L Hutchison; Shawheen Faghihahmadabadi; Scott L Davis; Jeremy F Strain; Jeffrey Spence; Daniel C Krawczyk; Hao Huang; Hanzhang Lu; John Hart; Teresa C Frohman; Elliot M Frohman; Darin T Okuda; Bart Rypma
Journal:  Hum Brain Mapp       Date:  2017-08-16       Impact factor: 5.038

Review 4.  Energy failure in multiple sclerosis and its investigation using MR techniques.

Authors:  David Paling; Xavier Golay; Claudia Wheeler-Kingshott; Raju Kapoor; David Miller
Journal:  J Neurol       Date:  2011-06-10       Impact factor: 4.849

5.  Multiple sclerosis shrinks intralesional, and enlarges extralesional, brain parenchymal veins.

Authors:  María I Gaitán; Manori P de Alwis; Pascal Sati; Govind Nair; Daniel S Reich
Journal:  Neurology       Date:  2012-12-19       Impact factor: 9.910

6.  Regional Frontal Perfusion Deficits in Relapsing-Remitting Multiple Sclerosis with Cognitive Decline.

Authors:  R Vitorino; S-P Hojjat; C G Cantrell; A Feinstein; L Zhang; L Lee; P O'Connor; T J Carroll; R I Aviv
Journal:  AJNR Am J Neuroradiol       Date:  2016-05-19       Impact factor: 3.825

7.  White matter hemodynamic abnormalities precede sub-cortical gray matter changes in multiple sclerosis.

Authors:  Andrew W Varga; Glyn Johnson; James S Babb; Joseph Herbert; Robert I Grossman; Matilde Inglese
Journal:  J Neurol Sci       Date:  2009-01-31       Impact factor: 3.181

Review 8.  Adrenergic and dopaminergic modulation of immunity in multiple sclerosis: teaching old drugs new tricks?

Authors:  Marco Cosentino; Franca Marino
Journal:  J Neuroimmune Pharmacol       Date:  2012-10-17       Impact factor: 4.147

Review 9.  Impaired Neurovisceral Integration of Cardiovascular Modulation Contributes to Multiple Sclerosis Morbidities.

Authors:  Zohara Sternberg
Journal:  Mol Neurobiol       Date:  2016-01-07       Impact factor: 5.590

10.  Using iron oxide nanoparticles to diagnose CNS inflammatory diseases and PCNSL.

Authors:  Brian T Farrell; Bronwyn E Hamilton; Edit Dósa; Endre Rimely; Morad Nasseri; Seymur Gahramanov; Cynthia A Lacy; Eugene P Frenkel; Nancy D Doolittle; Paula M Jacobs; Edward A Neuwelt
Journal:  Neurology       Date:  2013-06-14       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.